Stereoisomers ginsenosides-20(S)-Rg 3 and -20(R)-Rg 3 differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma

Biochemical Pharmacology

Volumn 83, Issue 7, 2012, Pages 893-902

  Kwok, Hoi Hin ^a   Guo, Guan Lun ^a   Lau, Justin Kai Chi ^a   Cheng, Yuen Kit ^a   Wang, Jiang Rong ^a   Jiang, Zhi Hong ^a   Keung, Man Hong ^a   Mak, Nai Ki ^a   Yue, Patrick Ying Kit ^a   Wong, Ricky Ngok Shun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Angiogenesis; Ginsenoside; PPAR ; Rg 3; Stereoisomer

Indexed keywords

GINSENOSIDE RG 3; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; LIGAND BINDING; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; STEREOISOMERISM;

ANGIOGENESIS INDUCING AGENTS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; COMPUTER SIMULATION; ENDOTHELIAL CELLS; FIBROBLASTS; GENES, REPORTER; GINSENOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR STRUCTURE; PPAR GAMMA; RNA, SMALL INTERFERING; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 84862830195     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.12.039     Document Type: Article

References (47)

1. S. Shibata, M. Fujita, H. Itokawa, O. Tanako, and T. Ishii Studies on the constituents of Japanese and Chinese Crude Drugs, XI, Panaxadiol, a sapogenin of ginseng roots Chem Pharm Bull (Tokyo) 11 1963 759 761
2. W.Y. Kim, J.M. Kim, S.B. Han, S.K. Lee, N.D. Kim, and M.K. Park Steaming of ginseng at high temperature enhances biological activity J Nat Prod 63 2000 1702 1704
3. 3 by Microbacterium sp. GS514 Phytochemistry 69 2007 218 224
4. 3 action on ion channels Mol Cells 18 2004 383 389
5. 3 epimers on swine coronary artery contractions Biol Pharm Bull 29 2006 365 370
6. 2 on prostate cancer cells Fitoterapia 81 2010 902 905
7. 2, not 20(S), is a selective osteoclastgenesis inhibition without any cytotoxicity Bioorg Med Chem Lett 19 2009 3320 3323
8. 3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway Biochem Biophys Res Commun 349 2006 987 994
9. Y.J. Lee, E. Chung, K.Y. Lee, Y.H. Lee, B. Huh, and S.K. Lee Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocortocoid receptor Mol Cell Endocrinol 133 1997 135 140
10. 1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/AKT/Nrf2-dependent pathway in human dopaminergic cells Toxicol Appl Pharmacol 242 2010 18 28
11. 3 involves the AMPK and PPAR-gamma signal pathways Phytother Res 23 2009 262 266
12. S.Z. Duan, M.G. Usher, and R.M. Mortensen PPARs: the vasculature, inflammation and hypertension Curr Opin Nephrol Hypertens 18 2009 128 133
13. C. Liang, Y. Ren, H. Tan, Z. He, Q. Jiang, and J. Wu Rosiglitazone via upregulation of AKT/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products Br J Pharmacol 158 2009 1865 1873
14. K. Chu, S.T. Lee, J.S. Koo, K.H. Jung, E.H. Kim, and D.I. Sinn Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia Brain Res 1093 2006 208 218
15. D. Cho, Y.J. Choi, S.A. Jo, and I. Jo Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone J Biol Chem 279 2004 2499 2506
16. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
17. R. Roskoski Jr. Vascular endothelial (VEGF) signaling in tumor progression Crit Rev Oncol Hematol 62 2007 179 213
18. P.Y. Yue, E.P. Leung, N.K. Mak, and R.N. Wong A simplified method for quantifying cell migration/wound healing in 96-well plates J Biomol Screen 15 2010 427 433
19. 3 Biochem Pharmacol 72 2006 437 445
20. R.T. Nolte, G.B. Wisely, S. Westin, J.E. Cobb, M.H. Lambert, and R. Kurokawa Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Nature 395 1998 137 143
21. Y. Li, M. Choi, K. Suino, A. Kovach, J. Daugherty, and A. Kliewer Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner Proc Natl Acad Sci USA 102 2005 9505 9510
22. Y. Li, A. Kovach, K. Suino-Powell, D. Martynowski, and H.E. Xu Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor γ to PGC-1α J Biol Chem 283 2008 19132 19139
23. M. Einstein, T.E. Akiyama, G.A. Castriota, C.F. Wang, B. McKeever, and R.T. Mosley The differential interactions of peroxisome proliferator-activated receptor (ligands with Tyr473 is a physical basis for their unique biological activities Mol Pharmacol 73 2008 62 74
24. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, and R.K. Belew Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J Comput Chem 19 1998 1639 1662
25. G. Pochetti, C. Godio, N. Mitro, D. Caruso, A. Galmozzi, and S. Scurati Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor (ligand-binding domain in the complex with two enantiomeric ligands J Biol Chem 282 2007 17314 17324
26. 3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB Eur J Pharamcol 631 2010 1 9
27. 2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy Cancer Chemother Pharmacol 64 2009 1085 1095
28. 1 possesses antiallergic and anti-inflammatory activities Int Arch Allergy Immunol 133 2004 113 120
29. G. Zhang, A. Liu, Y. Zhou, X. San, T. Jin, and Y. Jin Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia J Enthnopharmacol 115 2008 441 448
30. D.R. Brocks Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics Biopharm Drug Dispos 127 2008 387 406
31. V.L. Campo, L.S.C. Bernardes, and I. Carvalho Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods Curr Drug Metab 10 2009 188 205
32. J. McConathy, and M.J. Owens Stereochemistry and drug action. Primary care companion J Clin Psychiatry 5 2003 70 73
33. F. Jamali, R. Mehvar, and M. Pasutto Enantioselective aspects of drug action and disposition: therapeutic pitfalls J Pharm Sci 78 1989 695 715
34. 2: stereoselectivity and involvement of ABC transporters Xenobiotica 40 2010 602 612
35. G. Fracchiolla, A. Laghezza, L. Piemontese, G. Carbonara, A. Lavecchi, and P. Tortorella Synthesis, biological evaluation, and molecular modeling investigation of chrial phenoxyacetic acid analogues with PPARalpha and PPARgamma agonist activity ChemMedChem 2 2007 641 654
36. K. Kwok, and N. Cheung Measuring binding kinetics of ligands with tethered receptors by fluorescence polarization and total internal reflection fluorescence Anal Chem 82 2010 3819 3825
37. 2, an endogenous ligand of peroxisome proliferator-activated receptor γ, in tumor angiogenesis Biochem Pharm 76 2008 1544 1553
38. H. Lee, F.J. Gonzalez, and M. Yoon Ginsenoside Rf a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha Biochem Biophys Res Commun 339 2006 196 203
39. 2 are associated with the activation of AMPK signaling pathway in 3T3-L1 Biochem Biophys Res Commun 364 2007 1002 1008
40. K.L. Han, M.H. Jung, J.H. Sohn, and J.K. Hwang Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes Biol Pharm Bull 29 2006 110 113
41. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infraction and death from cardiovascular causes N Engl J Med 356 2007 2457 2571
42. 3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase Toxicol Appl Pharmacol 246 2010 171 183
43. S.G. Bernier, S. Haldar, and T. Michel Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase J Biol Chem 275 2000 30707 30715
44. Y.M. Kim, S. Namkoong, Y.G. Yun, H.D. Hong, Y.C. Lee, and K.S. Ha Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells Biol Pharm Bull 30 2007 1674 1679
45. M. Luconi, G. Cantini, and M. Serio Peroxisome proliferator-activated receptor gamma (PPAR(): Is the genomic activity the only answer Steroids 75 2010 585 594
46. L. Tencer, E. Burgermeister, M.P. Ebert, and M. Liscovitch Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance Anticancer Res 28 2008 895 906
47. Z.C. Dang, V. Audinot, S.E. Papapoulous, J.A. Boutin, and C.W. Löwik Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein J Biol Chem 278 2003 962 967